The FDA requires generic drugs to meet the same safety and effectiveness standards as brand-name drugs. Learn how bioequivalence testing, manufacturing rules, and strict oversight ensure generics are just as reliable - and why they save billions without compromising health.
Read More
Pharmacists verify generic equivalence using the FDA's Orange Book to ensure generics are therapeutically equivalent to brand-name drugs. This process relies on pharmaceutical and bioequivalence data, legal standards, and strict substitution rules to keep patients safe and costs low.
Read More
Pharmacokinetic studies are the primary method used to prove generic drugs work like brand-name versions, but they’re not foolproof. Learn how they work, where they fall short, and what’s changing in drug approval.
Read More